<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chen Q</submitter><funding>National Health and Medical Research Council</funding><funding>Australian Research Council</funding><pagination>813087</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8963460</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13</volume><pubmed_abstract>Coronavirus disease 2019 (COVID-19) caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an acute respiratory disease with systemic complications. Therapeutic strategies for COVID-19, including repurposing (partially) developed drugs are urgently needed, regardless of the increasingly successful vaccination outcomes. We characterized two-dimensional (2D) and three-dimensional models (3D) to establish a physiologically relevant airway epithelial model with potential for investigating SARS-CoV-2 therapeutics. Human airway basal epithelial cells maintained in submerged 2D culture were used at low passage to retain the capacity to differentiate into ciliated, club, and goblet cells in both air-liquid interface culture (ALI) and airway organoid cultures, </pubmed_abstract><journal>Frontiers in pharmacology</journal><pubmed_title>ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies.</pubmed_title><pmcid>PMC8963460</pmcid><funding_grant_id>IC170100016</funding_grant_id><funding_grant_id>1181637</funding_grant_id><pubmed_authors>Chen Q</pubmed_authors><pubmed_authors>Baker ML</pubmed_authors><pubmed_authors>Gartner MJ</pubmed_authors><pubmed_authors>Xia YC</pubmed_authors><pubmed_authors>Subbarao K</pubmed_authors><pubmed_authors>Todd S</pubmed_authors><pubmed_authors>Clarke N</pubmed_authors><pubmed_authors>Langenbach S</pubmed_authors><pubmed_authors>Li M</pubmed_authors><pubmed_authors>Pharo EA</pubmed_authors><pubmed_authors>Williams SM</pubmed_authors><pubmed_authors>Stewart AG</pubmed_authors><pubmed_authors>Gao X</pubmed_authors><pubmed_authors>Ranganathan S</pubmed_authors></additional><is_claimable>false</is_claimable><name>ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies.</name><description>Coronavirus disease 2019 (COVID-19) caused by infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an acute respiratory disease with systemic complications. Therapeutic strategies for COVID-19, including repurposing (partially) developed drugs are urgently needed, regardless of the increasingly successful vaccination outcomes. We characterized two-dimensional (2D) and three-dimensional models (3D) to establish a physiologically relevant airway epithelial model with potential for investigating SARS-CoV-2 therapeutics. Human airway basal epithelial cells maintained in submerged 2D culture were used at low passage to retain the capacity to differentiate into ciliated, club, and goblet cells in both air-liquid interface culture (ALI) and airway organoid cultures, </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2025-04-19T00:39:25.105Z</modification><creation>2025-04-07T11:41:23.486Z</creation></dates><accession>S-EPMC8963460</accession><cross_references><pubmed>35359837</pubmed><doi>10.3389/fphar.2022.813087</doi></cross_references></HashMap>